Resources
Search all resources on this page or select a tab to see publications, videos, audio, collections of related resources and more.
Resources for healthcare providers – National Cervical Screening Program
This collection explains the cervical screening program for health professionals. It also includes resources for patients.
Resources for Aboriginal and Torres Strait Islander women – National Cervical Screening Program
Healthcare providers can use the resources in this collection to explain cervical screening to Aboriginal and Torres Strait Islander women.
COVID-19 vaccination information for in-home and community aged care workers – are you up to date?
This fact sheet provides COVID-19 vaccination information for in-home and community aged care workers.
Monkeypox – Laboratory case definition
The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for monkeypox.
Part of a collection: Monkeypox (MPX) resourcesACAT Guidance Framework for Home Care Package Level
This framework is for Aged Care Assessment Teams (ACAT). It informs and supports their decision making when recommending Home Care Package levels.
Part of a collection: My Aged Care – Assessor Portal ResourcesNational Cervical Screening Program – Understanding the National Cervical Screening Program Management Pathway
Learn about the clinical pathway that supports the National Cervical Screening Program and the guidelines for pathology testing of cervical and vaginal samples.
Part of a collection: Resources for healthcare providers – National Cervical Screening ProgramATAGI recommendations on the use of a booster dose of COVID-19 vaccine
The Australian Technical Advisory Group on Immunisation (ATAGI) have developed recommendations on the use of additional (booster) doses of COVID-19 vaccine.
Part of a collection: COVID-19 vaccination – Provider resourcesAged care funding instrument (ACFI) monthly monitoring reports
A collection of recent ACFI monthly monitoring reports. These reports track the monthly growth in ACFI subsidies compared with estimates.
National Cervical Screening Program – Quick reference guide – Self-collected cervical screening tests
A quick reference guide for healthcare providers about the option of self-collection for cervical screening. It includes information on possible test results and follow-up requirements.
Part of a collection: Resources for healthcare providers – National Cervical Screening ProgramNational Cervical Screening Program – Quick reference guide – clinician-collected cervical screening tests
A quick reference guide for healthcare providers about the option of clinician-collection for cervical screening. It includes information on possible test results and follow-up requirements.
Part of a collection: Resources for healthcare providers – National Cervical Screening ProgramNational Cervical Screening Program – Pathology test guide for cervical and vaginal testing
This table shows the guidelines for pathology testing of cervical and vaginal samples.
Part of a collection: Resources for healthcare providers – National Cervical Screening ProgramCDGN, PHLN and CDNA sampling strategy for SARS-CoV-2 genomic surveillance
This Communicable Diseases Genomics Network (CDGN), Public Health Laboratory Network (PHLN) and Communicable Diseases Network Australia (CDNA) document contains a sampling strategy for SARS-CoV-2 genomic surveillance.
COVID-19 vaccination – Why is my residential aged care employer asking me if I have received a COVID-19 vaccination?
Information about reporting by residential aged care providers of COVID-19 workforce vaccinations, including what information aged care facilities will collect and report, and why a new reporting tool is being used.
Part of a collection: COVID-19 vaccination – New reporting requirements for aged careCOVID-19 vaccination – Booster information for residential aged care workers – are you up to date?
Information for workers about the booster doses including eligibility, when doses are recommended and the type of vaccine used.
Life Saving Drugs Program – Gaucher disease (type 1) – Guidelines
These guidelines contain the general, initial and ongoing eligibility requirements to access certain medications for Gaucher disease (type 1) under the Life Saving Drugs Program.
Part of a collection: Life Saving Drugs Program resources – Gaucher diseaseLife Saving Drugs Program – Gaucher disease (type 1) – Reapplication
Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for Gaucher disease.
Part of a collection: Life Saving Drugs Program resources – Gaucher diseaseLife Saving Drugs Program – Gaucher disease (type 1) – Initial application
Treating physicians use this application form to apply for a patient to access LSDP medication for Gaucher disease for the first time, or after a break.
Part of a collection: Life Saving Drugs Program resources – Gaucher diseaseLife Saving Drugs Program resources – Gaucher disease
A collection of resources for health professionals to help people with Gaucher disease (type 1) access the following drugs under the Life Saving Drugs Program: imiglucerase (Cerezyme®), velaglucerase (VPRIV®), and taliglucerase (Elelyso®).
Cost Recovery Implementation Statement – National Joint Replacement Registry – 1 July 2022 to 30 June 2023
This statement describes how the Department of Health recovers the costs of administering the National Joint Replacement Registry.
Part of a collection: Cost Recovery Implementation Statement (CRIS)Cost Recovery Implementation Statement – Administration of the Prostheses List – 1 July 2022 to 30 June 2023
This statement describes how the Department of Health recovers the costs of administering the Prostheses List.
Part of a collection: Cost Recovery Implementation Statement (CRIS)This webinar on 30 June is part of a series to update primary care on the COVID-19 response and the vaccine rollout. The panel will provide key updates and answer participants’ questions.
This webinar on 14 July is part of a series to update primary care on the COVID-19 response and the vaccine rollout. The panel will provide key updates and answer participants’ questions.
This webinar on 7 July is part of a series to update primary care on the COVID-19 response and the vaccine rollout. The panel will provide key updates and answer participants’ questions.
National interim guide to reduce children’s exposure to unhealthy food and drink promotion – 2018
This guide was originally created and published by the Council of Australian Governments (COAG) Health Council on 2 August 2018. It outlines food and drink categories that are not recommended for promotion to children in government settings.
Funding reform resources
This page contains links to more information and resources about residential aged care funding reforms.